Status:
COMPLETED
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
Lead Sponsor:
Lund University
Collaborating Sponsors:
Swedish Cancer Society
Conditions:
Human Papillomavirus Infection
Cervical Intraepithelial Neoplasia
Eligibility:
FEMALE
Brief Summary
The objectives are to evaluate the effectiveness of treatment of cervical intraepithelial neoplasia (CIN) by loop electrosurgical excision procedure using persistence of human papillomavirus (HPV) as ...
Detailed Description
Cervical samples for human papillomavirus (HPV) DNA analysis and cytological analysis were obtained from women with abnormal smears referred to Umeå university hospital, Sweden, for treatment with con...
Eligibility Criteria
Inclusion
- Referral to Umeå university hospital for treatment due to abnormal Pap smear.
Exclusion
- Lack of informed consent.
Key Trial Info
Start Date :
February 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2005
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT00931190
Start Date
February 1 2001
End Date
November 1 2005
Last Update
September 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. obstetrics and gynecology, University hospital of Northern Sweden
Umeå, Sweden, 90185